Clinical Trial Update: Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of rituximab and mesenchymal stem cells for nephrotic syndrome in patients with chronic kidney disease stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Nephrotic Syndrome

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)
• Rituximab (rituximab)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Renal Insufficiency, Chronic, Nephrotic Syndrome | Phase 2 | Status: UNKNOWN